Factors Associated with Chronic Chikungunya in Vitória, Espírito Santo State, Brazil, Between 2016 and 2020.

Creuza Rachel Vicente, Luana Santos Louro, Nicolli Ribeiro de Jesus, Danielle Torres Dos Santos Lopes, Aline Souza Areias Cabidelle, Crispim Cerutti Junior, Angelica Espinosa Barbosa Miranda, Iuri Drumond Louro, Debora Dummer Meira, Kuan Rong Chan
Author Information
  1. Creuza Rachel Vicente: Department of Social Medicine, Federal University of Espírito Santo, Vitória 29047-105, Espírito Santo State, Brazil. ORCID
  2. Luana Santos Louro: Medical School, Federal University of Espírito Santo, Vitória 29047-105, Espírito Santo State, Brazil.
  3. Nicolli Ribeiro de Jesus: Post-Graduate Program in Infectious Diseases, Federal University of Espírito Santo, Vitória 29047-105, Espírito Santo State, Brazil.
  4. Danielle Torres Dos Santos Lopes: Post-Graduate Program in Infectious Diseases, Federal University of Espírito Santo, Vitória 29047-105, Espírito Santo State, Brazil.
  5. Aline Souza Areias Cabidelle: Health Surveillance Service, Department of Health, Vitória 29017-010, Espírito Santo State, Brazil.
  6. Crispim Cerutti Junior: Department of Social Medicine, Federal University of Espírito Santo, Vitória 29047-105, Espírito Santo State, Brazil. ORCID
  7. Angelica Espinosa Barbosa Miranda: Department of Social Medicine, Federal University of Espírito Santo, Vitória 29047-105, Espírito Santo State, Brazil.
  8. Iuri Drumond Louro: Department of Animal Biology, Federal University of Espírito Santo, Vitória 29075-910, Espírito Santo State, Brazil.
  9. Debora Dummer Meira: Department of Animal Biology, Federal University of Espírito Santo, Vitória 29075-910, Espírito Santo State, Brazil.
  10. Kuan Rong Chan: Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore 169857, Singapore. ORCID

Abstract

Chikungunya patients may develop chronic joint pain that can persist for months to years. This study aimed to determine the factors associated with Chikungunya chronicity. This case-control study involved data from patients with laboratory-confirmed Chikungunya reported from March 2016 to December 2020 in Vitória, Espírito Santo state, Brazil. The data were accessed from compulsory notification databases (SINAN and eSUS VS) and electronic medical reports (Rede Bem-Estar). For each patient who developed chronic symptoms, we included a control patient who did not develop chronic symptoms by random sampling. A total of 183 chronic and 183 non-chronic patients were included in the study. Most of them were female (73.2%), with a median age of 49.5 years (interquartile range = 37-61), and presented fever (89.6%), myalgia (89.6%), arthralgia (89.3%), and headache (82.0%). Chronic patients were older (median = 53; interquartile range = 41-61) than non-chronic cases (median = 46; interquartile age = 31-61) (OR = 0.979, 95% CI = 0.968-0.991) and more frequently presented nausea (58.5% vs. 40.4%; OR = 2.109, 95% CI = 1.374-3.238), and leukopenia (20.2% vs. 10.9%; OR = 2.060, 95% CI = 1.122-3.779). Therefore, these characteristics should be monitored for the better clinical management of cases prone to chronicity.

Keywords

References

  1. Lancet Microbe. 2023 May;4(5):e319-e329 [PMID: 37031687]
  2. Mem Inst Oswaldo Cruz. 2017 Aug;112(8):523-531 [PMID: 28767976]
  3. PLoS Negl Trop Dis. 2020 Mar 12;14(3):e0007327 [PMID: 32163420]
  4. Rev Med Inst Mex Seguro Soc. 2018 Oct 25;56(3):239-245 [PMID: 30376273]
  5. Trans R Soc Trop Med Hyg. 2018 Jul 1;112(7):301-316 [PMID: 30007303]
  6. Arthritis Care Res (Hoboken). 2016 Dec;68(12):1849-1858 [PMID: 27015439]
  7. PLoS Negl Trop Dis. 2021 Mar 4;15(3):e0009055 [PMID: 33661908]
  8. Acta Trop. 2023 May;241:106872 [PMID: 36868369]
  9. Travel Med Infect Dis. 2020 May - Jun;35:101618 [PMID: 32160972]
  10. Int J Infect Dis. 2021 Apr;105:608-616 [PMID: 33684559]
  11. Int J Infect Dis. 2018 Feb;67:107-113 [PMID: 29277382]
  12. J Rheumatol. 2020 Aug 1;47(8):1267-1274 [PMID: 31263071]
  13. Epidemiol Infect. 2017 Jan;145(1):46-53 [PMID: 27609661]
  14. Trans R Soc Trop Med Hyg. 2019 Apr 1;113(4):221-226 [PMID: 30551206]
  15. Lancet Reg Health Am. 2023 Aug 11;25:100571 [PMID: 37638140]
  16. Viruses. 2019 Feb 20;11(2): [PMID: 30791607]
  17. PLoS One. 2023 Dec 22;18(12):e0296131 [PMID: 38134205]
  18. Rev Soc Bras Med Trop. 2019 Oct 03;52:e20190167 [PMID: 31596350]
  19. Eur J Clin Microbiol Infect Dis. 2018 Nov;37(11):2159-2164 [PMID: 30120648]
  20. Lancet Reg Health Am. 2024 Jan 08;30:100673 [PMID: 38283942]
  21. Nat Rev Dis Primers. 2023 Apr 6;9(1):17 [PMID: 37024497]
  22. Clin Rheumatol. 2020 May;39(5):1679-1686 [PMID: 31916107]
  23. Emerg Infect Dis. 2023 Sep;29(9):1859-1863 [PMID: 37488810]

Grants

  1. MOH-000610-00/National Medical Research Council
  2. 442106/2023-8/Brazilian National Council for Scientific and Technological Development
  3. 88887.927805/2023-00/Brazilian Coordination for the Improvement of Higher Education Personnel

MeSH Term

Humans
Chikungunya Fever
Brazil
Female
Middle Aged
Male
Adult
Case-Control Studies
Chronic Disease
Arthralgia
Chikungunya virus
Risk Factors
Aged
Fever
Myalgia
Headache

Word Cloud

Created with Highcharts 10.0.0=chronicChikungunyapatientsstudymedianinterquartile89OR95%CIdeveloppainyearschronicitydata20162020VitóriaEspíritoSantoBrazilpatientsymptomsincluded183non-chronic2%agerangepresentedfever6%arthralgiaChroniccases0vs21clinicalmayjointcanpersistmonthsaimeddeterminefactorsassociatedcase-controlinvolvedlaboratory-confirmedreportedMarchDecemberstateaccessedcompulsorynotificationdatabasesSINANeSUSVSelectronicmedicalreportsRedeBem-Estardevelopedcontrolrandomsamplingtotalfemale7349537-61myalgia3%headache820%older5341-614631-61979968-0991frequentlynausea585%404%109374-3238leukopenia20109%060122-3779ThereforecharacteristicsmonitoredbettermanagementproneFactorsAssociatedStatechikungunyaepidemiology

Similar Articles

Cited By